Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01827033
Other study ID # NA_00082735
Secondary ID
Status Terminated
Phase N/A
First received March 29, 2013
Last updated September 14, 2015
Start date March 2013
Est. completion date June 2013

Study information

Verified date November 2013
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This research is being done to learn about the effects of doing meditation (sitting quietly and concentrating) on people's ability to pay attention and be relaxed.


Recruitment information / eligibility

Status Terminated
Enrollment 6
Est. completion date June 2013
Est. primary completion date June 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- aged 18-55

- currently enrolled in methadone maintenance program

Exclusion Criteria:

- history of: a severe medical or psychiatric condition (except substance abuse; e.g., schizophrenia); brain trauma affecting cognitive functioning

- prior experience with meditation

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
meditation training


Locations

Country Name City State
United States BPRU, Johns Hopkins Bayview Medical Center Baltimore Maryland

Sponsors (1)

Lead Sponsor Collaborator
Johns Hopkins University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary computerized attention task discrimination score on the continuous performance task within 1 week after training No
Secondary stress questionnaires within 1 week after training No
Secondary mindfulness questionnaire within 1 week after training No